申请人:MERRELL DOW PHARMACEUTICALS INC.
公开号:EP0058435A2
公开(公告)日:1982-08-25
Novel 4-aroylimidazol-2-ones of the following general structure which are useful as antihypertensives, cardiotonics and antithrombotics
wherein Ar is 2-furyl, 2-thienyl or phenyl, the latter of which may optionally be substituted with one or two X groups; X is halogen, hydroxy, C1-4 alkyl, C1-4 alkoxy, methylenedioxy, C1-4 alkylthio, C1-4 alkylsulfoxide, C1-4 alkylsufone, CF3, -SO2N(R2)2, NR3R4, pyrrolidino, piperidino, morpholino, piperazino or N'-alkyl-piperazino, R is hydrogen, C1-4 alkyl, C1-4 alkylcarbonyl or benzyl; each of R1, R2, R3 and R4 are hydrogen or C1-4 alkyl; and the pharmaceutically acceptable salts thereof.
具有以下一般结构的新型 4-芳基咪唑-2-酮,可用作抗高血压药、强心剂和抗血栓药
其中 Ar 是 2-呋喃基、2-噻吩基或苯基,后者可任选被一个或两个 X 基团取代;X 是卤素、羟基、C1-4 烷基、C1-4 烷氧基、亚甲基二氧基、C1-4 烷硫基、C1-4 烷基亚砜、C1-4 烷基砜、CF3、-SO2N(R2)2、NR3R4、吡咯烷基、哌啶基、吗啉基、哌嗪基或 N'- 烷基哌嗪基,R 是氢、C1-4 烷基、C1-4 烷基羰基或苄基;R1、R2、R3 和 R4 各为氢或 C1-4 烷基;及其药学上可接受的盐类。